Treatment of bullous pemphigoid with enteric-coated mycophenolate sodium.
Tursen
U
U
Guney
A
A
Kaya
T
T
Ikizoglu
G
G
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003176:Complement C3 / Q000032:analysis; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D010391:Pemphigoid, Bullous / Q000188:drug therapy*; D011239:Prednisolone / Q000627:therapeutic use; D013608:Tablets, Enteric-Coated
D000893:Anti-Inflammatory Agents; D003176:Complement C3; D005938:Glucocorticoids; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D013608:Tablets, Enteric-Coated; D011239:Prednisolone; D009173:Mycophenolic Acid